These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28869493)

  • 1. Vaccines against Botulism.
    Sundeen G; Barbieri JT
    Toxins (Basel); 2017 Sep; 9(9):. PubMed ID: 28869493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What next for botulism vaccine development?
    Webb RP; Smith LA
    Expert Rev Vaccines; 2013 May; 12(5):481-92. PubMed ID: 23659297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism.
    Webb RP; Smith TJ; Smith LA; Wright PM; Guernieri RL; Brown JL; Skerry JC
    Toxins (Basel); 2017 Sep; 9(9):. PubMed ID: 28869522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of vaccines for prevention of botulism.
    Byrne MP; Smith LA
    Biochimie; 2000; 82(9-10):955-66. PubMed ID: 11086225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination of cattle with a recombinant bivalent toxoid against botulism serotypes C and D.
    Cunha CE; Moreira GM; Salvarani FM; Neves MS; Lobato FC; Dellagostin OA; Conceição FR
    Vaccine; 2014 Jan; 32(2):214-6. PubMed ID: 24252701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual and bivalent vaccines against botulinum neurotoxin serotypes A and B using DNA-based Semliki Forest virus vectors.
    Yu Y; Yu J; Li N; Wang S; Yu W; Sun Z
    Vaccine; 2009 Oct; 27(44):6148-53. PubMed ID: 19712769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative vaccination against equine botulism (BoNT/C).
    Frey J; Eberle S; Stahl C; Mazuet C; Popoff M; Schatzmann E; Gerber V; Dungu B; Straub R
    Equine Vet J; 2007 Nov; 39(6):516-20. PubMed ID: 18065309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines against botulism.
    Karalewitz AP; Barbieri JT
    Curr Opin Microbiol; 2012 Jun; 15(3):317-24. PubMed ID: 22694934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent tetravalent replicon vaccines against botulinum neurotoxins using DNA-based Semliki Forest virus replicon vectors.
    Yu YZ; Guo JP; An HJ; Zhang SM; Wang S; Yu WY; Sun ZW
    Vaccine; 2013 May; 31(20):2427-32. PubMed ID: 23583890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant holotoxoid vaccine against botulism.
    Pier CL; Tepp WH; Bradshaw M; Johnson EA; Barbieri JT; Baldwin MR
    Infect Immun; 2008 Jan; 76(1):437-42. PubMed ID: 17967862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentavalent replicon vaccines against botulinum neurotoxins and tetanus toxin using DNA-based Semliki Forest virus replicon vectors.
    Yu YZ; Liu S; Ma Y; Gong ZW; Wang S; Sun ZW
    Hum Vaccin Immunother; 2014; 10(7):1874-9. PubMed ID: 25424795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum neurotoxin vaccines: past, present, and future.
    Smith LA; Rusnak JM
    Crit Rev Immunol; 2007; 27(4):303-18. PubMed ID: 18197811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candidate vaccine against botulinum neurotoxin serotype A derived from a Venezuelan equine encephalitis virus vector system.
    Lee JS; Pushko P; Parker MD; Dertzbaugh MT; Smith LA; Smith JF
    Infect Immun; 2001 Sep; 69(9):5709-15. PubMed ID: 11500447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced immune responses using plasmid DNA replicon vaccine encoding the Hc domain of Clostridium botulinum neurotoxin serotype A.
    Yu YZ; Zhang SM; Sun ZW; Wang S; Yu WY
    Vaccine; 2007 Dec; 25(52):8843-50. PubMed ID: 18022294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective potential of recombinant non-purified botulinum neurotoxin serotypes C and D.
    Moreira C; da Cunha CE; Moreira GM; Mendonça M; Salvarani FM; Moreira ÂN; Conceição FR
    Anaerobe; 2016 Aug; 40():58-62. PubMed ID: 27236078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivalent Chromosomal Expression of the Clostridium botulinum Serotype A Neurotoxin Heavy-Chain Antigen and the Bacillus anthracis Protective Antigen in Lactobacillus acidophilus.
    O'Flaherty S; Klaenhammer TR
    Appl Environ Microbiol; 2016 Oct; 82(20):6091-6101. PubMed ID: 27496774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective efficacy of recombinant bacterin vaccine against botulism in cattle.
    Moreira C; Ferreira MRA; Finger PF; Magalhães CG; Cunha CEP; Rodrigues RR; Otaka DY; Galvão CC; Salvarani FM; Moreira ÂN; Conceição FR
    Vaccine; 2020 Mar; 38(11):2519-2526. PubMed ID: 32037222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral Response of Buffaloes to a Recombinant Vaccine against Botulism Serotypes C and D.
    Otaka DY; Barbosa JD; Moreira C; Ferreira MRA; Cunha CEP; Brito ARS; Donassolo RA; Moreira ÂN; Conceição FR; Salvarani FM
    Toxins (Basel); 2017 Sep; 9(10):. PubMed ID: 28937601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and evaluation of a recombinant subunit vaccine against botulinum neurotoxin serotype B using a 293E expression system.
    Yu Y; Shi D; Liu S; Gong ZW; Wang S; Sun Z
    Hum Vaccin Immunother; 2015; 11(2):468-73. PubMed ID: 25483668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of recombinant botulism antigens: a review of expression systems.
    Moreira GM; Cunha CE; Salvarani FM; Gonçalves LA; Pires PS; Conceição FR; Lobato FC
    Anaerobe; 2014 Aug; 28():130-6. PubMed ID: 24930432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.